Cintas (CTAS) is expected to continue benefiting from strong customer demand, higher sales growth, and healthy profit margins after a strong Q1 performance, UBS said in a note Thursday.
Cintas delivered better-than-expected growth across its business, with stronger new customer wins and cross-selling helping support future revenue growth as organic revenue growth reached 8.9% in Q1, and profit margins improved after cost management and efficiency gains, according to the note.
The investment firm said Cintas' uniform rental and first aid businesses showed solid growth, with first aid performing particularly well during the quarter.
UBS raised its fiscal 2027 and fiscal 2028 earnings estimates, citing stronger expected sales growth and slightly higher margin expectations.
UBS maintained its buy rating for Cintas and raised its price target to $235 from $230.
Price: $197.60, Change: $+5.63, Percent Change: +2.93%